Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain

S al-Obeid1, D Billot-Klein, J van Heijenoort

  • 1Laboratoire de Microbiologie Médicale, Université Paris VI, France.

FEMS Microbiology Letters
|February 1, 1992
PubMed

Insights

Penicillin and vancomycin synergy in resistant E. faecium occurs because high-affinity penicillin-binding proteins (PBPs) compensate for reduced PBP5 function after vancomycin resistance is induced.

Area of Science:

  • Microbiology
  • Antibiotic Resistance
  • Biochemistry

Background:

  • Penicillin-resistant Enterococcus faecium (E. faecium) poses a significant clinical challenge.
  • Vancomycin resistance in E. faecium is often mediated by inducible resistance mechanisms.
  • Understanding antibiotic synergy is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To elucidate the mechanism of synergy between vancomycin and penicillin in a vancomycin-resistant E. faecium strain.
  • To investigate the role of penicillin-binding proteins (PBPs) in this synergistic interaction.

Main Methods:

  • Utilized a penicillin-resistant E. faecium strain (D366) with inducible vancomycin resistance.
  • Assessed the effect of penicillin on the expression of vancomycin resistance determinants (VANB protein and carboxypeptidase activity).
  • Performed competition assays with radiolabeled penicillin and various beta-lactam antibiotics to study PBP binding affinities.

Main Results:

  • Penicillin alone did not reduce the inducible expression of the VANB protein or associated carboxypeptidase activity.
  • Synergy is explained by the shift in function to high-molecular mass PBPs (potentially PBP1) with high beta-lactam affinity.
  • These high-affinity PBPs assume the role of the low-affinity PBP5, which confers resistance in the non-induced state.

Conclusions:

  • The synergy between vancomycin and penicillin in this E. faecium strain is not due to reduced vancomycin resistance gene expression.
  • The mechanism involves a functional compensation by high-affinity PBPs once vancomycin resistance is induced.
  • This highlights the complex interplay of PBPs in antibiotic resistance and synergy.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...